TREC@TAMU Cancer Prevention Registry and Repository

This study is creating a registry and repository to collect health and genetic information. Researchers want to understand how genetics, diet, exercise, and jobs affect your risk of developing certain cancers. The goal is to use this knowledge to help doctors and health insurers improve ways to prevent cancers that are hard to treat. You may be able to join if you are 18 or older and are participating in a specific cancer screening program in Bryan and Navasota, or if you have certain health conditions like COPD (chronic obstructive pulmonary disease), liver disease, or cervical intraepithelial neoplasia (CIN) lesions. The study aims to enroll 2500 people. The current recruitment status is unclear.

Study design: This is an observational study, meaning researchers will collect information without giving any specific treatments. It plans to enroll 2500 participants.
What's involved: Not specified in the trial record.
Compensation: Not stated in the trial record.
Follow-up: The study will measure the frequency and nature of adverse drug reactions (ADRs) using the Naranjo Scale Questionnaire at 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

TREC@TAMU Cancer Prevention Registry and Repository

Recruiting

Not specifiedAges 18+Observational

Texas A&M University

~2,500 participants

Updated 2025-02-13 on ClinicalTrials.gov

At a glance

Recruiting sites

1 of 1 listed site is recruiting right now

RecruitingSuspended, closed, or not yet open

What they're measuring

Frequency and nature of ADRs on the Naranjo Scale Questionnaire

Measured over 5 years

Conditions

Cancer

Genetics

Disease

Diet

Lifestyle Factors

Where it's being run

1 sites across 1 states

Texas1

Who to contact

Kenneth S Ramos, MD

[email protected]

7136777740

Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime

Eligibility criteria

Inclusion

18 years of age and older, and,

People participating in the Cancer Prevention and Research Institute of Texas (CPRIT) A coordinated cancer screening research program in Bryan and Navasota Family Medicine Clinics and,

People with COPD, liver disease, cervical intraepithelial neoplasia (CIN) lesions, having had a colonoscopy or a low dose computed tomography (LDCT) lung scan or cervical exam in the last 12 months or scheduled for one, and,

Able to give and comprehend the consent process, and,

Able to consent to donate blood and urine samples, genetic material through buccal swabs for future research, and,

Able to understand that their specimens, health record, and changes in health status will be followed for a five-year period and shared in deidentified form with the research community, and,

All sexes and gender identities.

Exclusion

Declines to participate or interact with staff/share their medical status.

A diagnosis of Alzheimer's disease or related dementias in a medical record indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning Individuals who are unable or unwilling to provide consent will be excluded

What this trial measures

Frequency and nature of ADRs on the Naranjo Scale Questionnaire5 years
Measure the frequency and nature of adverse drug reactions by obtaining a complete medical history and physical examination and validating the patient's current concomitant medication list during the office visit. Patient medical information would be input into the ActX platform, which functions as a computable EHR medical record analysis, evaluation of polypharmacy status, and monitoring of ADRs using the Naranjo Scale will be conducted for the duration of the study.

Trialytics